Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2017 042 579.6 |
96 | EP file number | EAKZ | 17 79 7066.2 |
86 | WO file number | WAKZ | PCT/EP2017/076911 |
97 | EP publication number | EPN | 3529262 |
87 | WO publication number | WPN | 2018073440 |
54 | Designation/title | TI | VERFAHREN UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR FÖRDERUNG DER T-ZELLENANTWORT |
51 | IPC main class | ICM (ICMV) | C07K 14/47 (2006.01) |
22 | DE application date | DAT | Oct 20, 2017 |
96 | EP application date | EAT | Oct 20, 2017 |
86 | WO application date | WAT | Oct 20, 2017 |
43 | Date of first publication | OT | Apr 26, 2018 |
| Date of publication of grant | PET | Jul 21, 2021 |
71/73 | Applicant/owner | INH | INSERM - Institut National de la Santé et de la Recherche Médicale, Paris, FR; Nantes Université, Nantes, FR; OSE Immunotherapeutics, Nantes, FR |
72 | Inventor | IN | CHIFFOLEAU, Elise, 44093 Nantes - Cedex 1, FR; TEPPAZ, Géraldine, 44800 St Herblain, FR; POIRIER, Nicolas, 44119 Treillieres, FR; Vanhove, Bernard, 44400 Rezé, FR; GAUTTIER, Vanessa, 44400 Rezé, FR |
| Address for service | | INSERM - Institut National de la Santé et de la Recherche Médicale, 75013 PARIS, FR |
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 16306381 Oct 21, 2016
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 17305988 Jul 24, 2017
|
| Due date | FT FG | Oct 31, 2025 Annual fee for the 9th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003529262A1 Searchable text:
EP000003529262A1 Original document:
EP000003529262B1 Searchable text:
EP000003529262B1 Original document:
WO002018073440 Searchable text:
WO002018073440 |
43 | Date of first publication | EVT | Apr 26, 2018 |
| Date of the first transfer into DPMAregister | EREGT | Aug 28, 2019 |
| Date of the (most recent) update in DPMAregister | REGT | Jul 16, 2025 (Show all update days)(Hide all update days)- Jul 16, 2025
- Applicant/owner: changed
- Representative: deleted
- Address for service: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 21.07.2021: new
- Procedures: New applicant/owner details, New applicant/owner details, 15.07.2025: new
- Procedures: New representative details, New representative details, 15.07.2025: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 21.07.2021: deleted
- Oct 18, 2024
- Aug 28, 2019
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 15, 2025 |
71/73 | Applicant/owner | INH | INSERM - Institut National de la Santé et de la Recherche Médicale, Paris, FR; Nantes Université, Nantes, FR; OSE Immunotherapeutics, Nantes, FR |
71/73 | Previous applicant/owner | INHF | INSERM - Institut National de la Santé et de la Recherche Médicale, Paris, FR, OSE Immunotherapeutics, Nantes, FR, Université de Nantes, Nantes, FR |
| Date of update of the procedure | REGT | Jul 16, 2025 |